Related Experiment Video
Updated: Nov 5, 2025
06:09
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
394
Requirements for Cannabis Product Labeling by U.S. State
Daniel J Kruger1,2, Natalie J Korach3, Jessica S Kruger2
1Population Studies Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA.
Cannabis and Cannabinoid Research
|May 17, 2021
Summary
Cannabis product labeling varies significantly across U.S. states, highlighting a need for standardized regulations. Implementing consistent labeling for marijuana products will enhance consumer safety and promote responsible use.
Area of Science:
- Public Health
- Regulatory Science
- Pharmacology
Background:
- Increasing legalization of medical and adult-use cannabis necessitates consumer safety measures.
- Standardized labeling in food and pharmaceuticals improves consumer understanding and safety.
- Current cannabis product labeling requirements lack uniformity across U.S. states.
Purpose of the Study:
- To investigate and analyze the current landscape of cannabis product labeling requirements in the United States.
- To identify common and variable labeling mandates across states with medical cannabis programs.
Main Methods:
- A comprehensive review of state regulatory publications from 31 U.S. states with medical cannabis programs.
- Compilation and analysis of mandatory information for cannabis product labeling.
Main Results:
- Significant variability in labeling requirements was observed among U.S. states.
- All states mandated delta-9-tetrahydrocannabinol (THC) content and manufacturer contact information.
- Over 80% of states required batch number, health risks, production tracking, a cannabis symbol, cannabidiol (CBD) content, and disclaimers for children and impairment.
Conclusions:
- A standardized, comprehensive framework for cannabis product labeling is essential for public protection.
- Standardization will maximize benefits, minimize harms, and promote safer, more effective cannabis product usage.
- While not statistically significant, states with adult-use cannabis showed a trend toward more recommended label attributes.
Related Concept Videos
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
55
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
55
01:17Drug Nomenclature
2.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.6K
01:25Drug Regulation
2.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.2K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
467
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
467
01:06Altered States of Awareness
713
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
713
01:26FDA Approved Drugs: Changes to Approved Drugs
40
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
40